摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bis[ palladium(II)(μ-acetato)(azobenzene)] | 107079-46-9

中文名称
——
中文别名
——
英文名称
bis[ palladium(II)(μ-acetato)(azobenzene)]
英文别名
bis[acetoxy(2-(phenylazo)phenyl)palladium];[Pd(phenylazophenyl(-1H))(μ-CH3COO)]2
CAS
107079-46-9;107035-15-4;55740-67-5
化学式
C28H24N4O4Pd2
mdl
——
分子量
693.363
InChiKey
JKZNBEJSNFDXHA-ZRVBCOBJSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    钯(II)的羟基配合物对腈的反应性:钯(II)的羧酰胺和亚氨基醚衍生物的形成
    摘要:
    通过加成制备双核羟基配合物[Pd 2(C,N)2(µ -OH)2 ] [C,N = 2-(二甲基氨基甲基)苯基(dmba)或2-(苯基偶氮)苯基(az)]。的2个当量的国家银行4 OH成相应的二- μ -乙酸甲酯络合物在丙酮中。两种羟基配合物与许多腈RCN的反应均导致形成羧酰胺配合物[Pd 2(C,N)2(µ - N HC(R)O)2 ](R = Me,Ph或CH 2 CH)以及琥珀腈衍生物[(C,N)Pd { N HC(O)CH 2 CH 2 C(O)N H} Pd(C,N)]。配合物[Pd 2(C,N)2(μ - N HC(Me)O)2 ]也可以通过[Pd 2(C,N)2(μ -OH)2 ]与乙酰胺反应制备。羟基络合物[Pd 2(C 6 F 5)4(µ -OH)2 ] 2–与腈在甲醇或乙醇中反应,生成亚氨基醚络合物[Pd(C 6 F5) 2 { N HC(OR')R} 2 ](R = Ph,R'=
    DOI:
    10.1039/a903262b
  • 作为产物:
    描述:
    di-μ-chlorobis(azobenzene-2C,N)dipalladium(II) 在 styrene 、 acetic acid 作用下, 以 为溶剂, 生成 bis[ palladium(II)(μ-acetato)(azobenzene)]
    参考文献:
    名称:
    Janecki, Tomasz; Jeffreys, John A. D.; Pauson, Peter L., Organometallics, 1987, vol. 6, # 7, p. 1553 - 1560
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Synthesis and characterisation of cyclometallated palladium(<scp>ii</scp>) complexes with phosphine–carboxylate and phosphine–amide ligands
    作者:Gregorio Sánchez、Joaquín García、David Meseguer、José L. Serrano、Luis García、José Pérez、Gregorio López
    DOI:10.1039/b310843k
    日期:——
    coordination properties of hybrid phosphino-amide ligands o-Ph2PC6H4CONHR [R = iPr (a), Ph (b)] have been investigated. New cyclometallated palladium(II) complexes in which a and b act as P-monodentate ligands have been synthesised by reacting them with selected cyclometallated precursors containing bridging chloride or acetate groups. The crystal structures of the compounds [Pd(Bzq)(o-Ph2PC6H4CO–NHiPr)(Cl)]
    杂化膦酰胺的配位性能 配体 o -Ph 2 PC 6 H 4 CONHR [R = i Pr(a),Ph(b)]已被研究。a和b充当P单齿的新型环属化(II)配合物配体通过使它们与含有桥联的乙酸基团的选定的环属化的前体反应来合成它们。化合物[Pd(BZq)(o -Ph 2 P C 6 H 4 CO–NH i Pr)(Cl)]和[Pd(Phox)(o -Ph 2 P C 6 H 4 CO–NH )的晶体结构i Pr)(CH 3 COO)](z= 7,8-苯并喹啉基; 已确定Phox = 2-(2-恶唑啉基)苯基)。协调性配体 当b与某些环属化骨架结合时,就会检测到b。刚性的P,O螯合行为配体由晶体结构确定证实[BZQ)(Ô -Ph 2 P c ^ 6 ħ 4 Ç ö -NH我PR)] [PF 6 ],在通过加入化学计量的KPF获得复合物观察到6至[( C ^ N)(μ-Cl)]
  • Aerobic photooxidation and C–C bond cleavage of the acetylacetonate ligand in (2-arylazo)arylpalladium(<scp>II</scp>) complexes induced by visible light
    作者:José Vicente、Aurelia Arcas、Delia Bautista、Georgiy B. Shul'Pin
    DOI:10.1039/dt9940001505
    日期:——
    (Arylazo)aryl(acetylacetonato)palladium(II) complexes, [Pd(4-RC6H3N=NC6H4R-4')(O,O-acac)] (R = H 1a, Me 1b or OMe 1c; Hacac = acetylacetone), upon irradiation of their acetone solutions at room temperature by UV, or even long-wavelength visible (lambda > 500 nm) light, were readily oxidized by atmospheric oxygen to give the corresponding acetato derivatives [Pd(4-RC6H3N=NC6H4R-4')(mu-O2-CMe)]2 (R = H 2a, Me 2b or OMe 2c), providing a model for some chemical and biological processes. The oxidation reaction of complex 1b was first order in the complex when [1b]0 less-than-or-equal-to 2 x 10(-3) mol dm-3. Complexes 1b and 1c were photooxidized at approximately twice the rate of complex la. In the presence of a scavenger of C-centred radicals (CCl4) the rate of complex 2b accumulation was reduced. When pyridine was added or co-ordinating solvents (acetonitrile or nitromethane) were used no photooxidation of complex 1 occurred. In the presence of PPh3 an induction period was observed and the oxidation of 1 started only after all the PPh3 was oxidized under irradiation into OPPh3. Spectroscopic data suggested that these ligands inhibit this photochemical oxidation because they change the type of co-ordination of the azobenzene chromophore and/or the acac ligands inducing a disconnection between the chromophore (antenna) and the acac ligand.
    (偶氮芳香基)芳香乙酰丙酮(II)配合物,[Pd(4-RC6H3N=NC6H4R-4')(O,O-acac)] (R = H 1a, Me 1b 或 OMe 1c; Hacac = 乙酰丙酮),当它们的丙酮溶液在室温下受到紫外线或甚至长波可见光(λ > 500 nm)照射时,很容易被大气氧氧化,生成对应的乙酸酯衍生物[Pd(4-RC6H3N=NC6H4R-4')(μ-O2-CMe)]2 (R = H 2a, Me 2b 或 OMe 2c),为某些化学生物过程提供了一个模型。当[1b]0 ≤ 2 × 10⁻³ mol dm⁻³时,配合物1b的氧化反应对自身浓度呈一级反应。配合物1b和1c的光氧化速率约为配合物1a的两倍。在存在捕获中心自由基的试剂(CCl4)时,2b的积累速率降低。加入吡啶或使用协同溶剂(乙腈硝基甲烷)时,1号配合物不会发生光氧化。在PPh3存在下,观察到一个诱导期,1号配合物的氧化仅在所有PPh3在光照下被氧化为OPPh3后才开始。光谱数据显示,这些配体通过改变偶氮苯色团和/或乙酰丙酮配体的配位类型,引起色团(天线)与乙酰丙酮配体之间的断开,从而抑制这种光化学氧化。
  • Synthesis and characterization of new cyclometallated Pd(II) complexes with bridging or terminal imidato ligands. Crystal structures of [{Pd(μ-succinimide)(phpy)}2] and [Pd(azb)(succinimide)(PPh3)] (phpy = 2-phenylpyridine; azb=azobenzene)
    作者:José Luis Serrano、Luis Garcı́a、José Pérez、Eduardo Pérez、Jorge Vives、Gregorio Sánchez、Gregorio López、Elies Molins、A.Guy Orpen
    DOI:10.1016/s0277-5387(02)01041-0
    日期:2002.7
    Two series of new dinuclear cyclometallated palladium complexes [Pd(mu-NCO)(C<^>N)}(2)] containing asymmetric imidato NCO- bridging units have been synthesized [C <^> N = azobenzene (azb); -NCO- = succinimide (1a), phthalimide (2a) or maleimide (3a); C <^> N = 2-phenylpyridine (phpy); -NCO- = succinimide (1b), phthalimide (2b) or maleimide (3b)]. The reaction of both succinimidato precursors with tertiary phosphines to form the mononuclear N-bonded imidato derivatives of general Formula [Pd(C <^> N)(suc)(L)] [C <^> N = azb; L - PPh3 (4a), PPh2Me (5a), PPhMe2 (6a), P(4-F-C6H4)(3). (7a), P(4-MeO-C6H4)(3) (8a) C <^> N = phpy L = PPh3 (4b), PPh2Me (5b), PPhMe2 (6b), P(4-F-C6H4)(3) (7b), P(4-MeO-C6H4)(3) (8b)] has been investigated. The new complexes were characterized by partial elemental analyses and spectroscopic methods (IR, FAB, H-1, C-13 and P-31). The single-crystal structures of 1b and 4a have been established. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫